Investing.com - Abbott Labs (NYSE:ABT) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Abbott Labs announced earnings per share of $0.65 on revenue of $7.73B. Analysts polled by Investing.com anticipated EPS of $0.63 on revenue of $7.59B. That with comparison to EPS of $0.63 on revenue of $7.54B in the same period a year before.Abbott Labs had reported EPS of $0.95 on revenue of $8.31B in the previous quarter.Analysts are expecting EPS of $0.66 and revenue of $7.36B in the upcoming quarter.
Abbott Labs shares are up 4% from the beginning of the year and are trading at $93.30 , down-from-52-week-high.They are outperforming the S&P 500 which is down 14.22% year to date.
Abbott Labs shares gained 2.60% in pre-market trade after the report.
Abbott Labs follows other major Healthcare sector earnings this month
Abbott Labs's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $1.99 on revenue of $19.86B.
Biontech had missed expectations on Tuesday, March 31, 2020 with first quarter EPS of $-0.27 on revenue of $30.72M, compared to forecast for EPS of $-0.19 on revenue of $33.28M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar